Journal of Clinical Virology
Volume 38, Issue 1 , Pages 39-43 , January 2007

Evaluation of NucliSens EasyQ™ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia

  • H.Y. Lam

      Affiliations

    • Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • J.H.K. Chen

      Affiliations

    • Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • K.H. Wong

      Affiliations

    • Integrated Treatment Centre, Special Preventive Programme, Centre of Health Protection, Department of Health, Hong Kong SAR, China
  • ,
  • K. Chan

      Affiliations

    • Integrated Treatment Centre, Special Preventive Programme, Centre of Health Protection, Department of Health, Hong Kong SAR, China
  • ,
  • P. Li

      Affiliations

    • Department of Medicine, The Queen Elizabeth Hospital, Hong Kong SAR, China
  • ,
  • M.P. Lee

      Affiliations

    • Department of Medicine, The Queen Elizabeth Hospital, Hong Kong SAR, China
  • ,
  • D.N. Tsang

      Affiliations

    • Department of Pathology, The Queen Elizabeth Hospital, Hong Kong SAR, China
  • ,
  • K.Y. Yuen

      Affiliations

    • Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • W.C. Yam

      Affiliations

    • Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • Corresponding Author InformationCorresponding author. Tel.: +852 28554892; fax: +852 28551241.

Received 24 June 2006 ,Revised 6 October 2006 ,Accepted 6 October 2006.

References 

  1. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Meth Med Res. 1999;8(2):135–160
  2. de Mendoza C, Koppelman M, Montes B, Ferre V, Soriano V, Cuypers H, et al. Multicenter evaluation of the NucliSens EasyQ HIV-1 version 1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Meth. 2005;127(1):54–59
  3. Dyer JR, Pilcher CD, Shepard R, Schock J, Eron JJ, Fiscus SA. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 1999;37(2):447–449
  4. Ginocchio CC, Tetali S, Washburn D, Zhang F, Kaplan MH. Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays. J Clin Microbiol. 1999;37(4):1210–1212
  5. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–954
  6. Murphy DG, Cote L, Fauvel M, Rene P, Vincelette J. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2000;38(11):4034–4041
  7. O’Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med. 1997;126(12):939–945
  8. Oelrichs RB, Crowe SM. The molecular epidemiology of HIV-1 in South and East Asia. Curr HIV Res. 2003;1(2):239–248
  9. Powderly WG, Saag MS, Chapman S, Yu G, Quart B, Clendeninn NJ. Predictors of optimal virological response to potent antiretroviral therapy. AIDS. 1999;13(14):1873–1880
  10. Raboud JM, Montaner JS, Conway B, Rae S, Reiss P, Vella S, et al. Suppression of plasma viral load below 20copies/mL is required to achieve a long-term response to therapy. AIDS. 1998;12(13):1619–1624
  11. Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet. 2004;364(9428):69–82
  12. Stevens W, Wiggill T, Horsfield P, Coetzee L, Scott LE. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. J Virol Meth. 2005;124(1/2):105–110
  13. Su L, Graf M, Zhang Y, von Briesen H, Xing H, Kostler J, et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B’) recombinant strain in China. J Virol. 2000;74(23):11367–11376
  14. Sun R, Ku J, Jayakar H, Kuo JC, Brambilla D, Herman S, et al. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 1998;36(10):2964–2969
  15. Van Beuningen R, Marras SA, Kramer FR, Oosterlaken T, Weusten J, Borst G, et al. Development of a high throughput detection system for HIV-1 using real-time NASBA based on molecular beacons. In:  Raghavachari R,  Tan WH editor. Genomics and proteomics technologies, Proceedings of SPIE, vol. 4264. Washington, DC: Society of Photo-optical Instrumentation Engineers; 2001;p. 66–71
  16. Weusten JJ, Carpay WM, Oosterlaken TA, van Zuijlen MC, van de Wiel PA. Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons. Nucl Acids Res. 2002;30(6):e26
  17. Yam WC, Chen JH, Wong KH, Chan K, Cheng VC, Lam HY, et al. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong. J Clin Virol. 2006;35:454–457
  18. Yang R, Kusagawa S, Zhang C, Xia X, Ben K, Takebe Y. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol. 2003;77(1):685–695
  19. Yao J, Liu Z, Ko LS, Pan G, Jiang Y. Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. J Virol Meth. 2005;129(1):40–46
  20. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA. 2004;292(2):251–265

PII: S1386-6532(06)00372-6

doi: 10.1016/j.jcv.2006.10.002

Journal of Clinical Virology
Volume 38, Issue 1 , Pages 39-43 , January 2007